The safety of carotid stenosis during vasodilator pharmacologic stress testing

William Perucki1, Ana Becerra2, Olivia Blazek1

  • 1Division of Cardiology, Hartford Hospital, 80 Seymour Street, Hartford, CT, 06102, USA.

Insights

Stress testing appears safe for patients with carotid artery disease, with no increased risk of adverse events observed in those with severe carotid stenosis. Further research is needed due to the study

Area of Science:

  • Cardiology
  • Neurology
  • Vascular Medicine

Background:

  • Carotid artery disease (CAD) poses risks for cerebrovascular accidents and transient ischemic attacks.
  • The safety of stress testing in patients with CAD is not well-defined.
  • Thousands of patients undergo stress testing annually, necessitating risk assessment in this population.

Purpose of the Study:

  • To evaluate the risk of adverse events associated with stress testing in patients with varying degrees of carotid artery disease.
  • To compare the incidence of cerebrovascular events, syncope, and other adverse outcomes between patients with and without significant carotid stenosis undergoing stress tests.
  • To assess hemodynamic responses during stress testing in patients with carotid stenosis.

Main Methods:

  • Retrospective review of patients with carotid evaluation (ultrasound or CTA) and stress testing within 180 days.
  • Exclusion of patients with intervening carotid intervention.
  • Primary endpoint: cerebrovascular event or syncope within 24 hours. Secondary endpoints: death, myocardial infarction, urgent procedures, or exaggerated hemodynamic response.
  • Propensity matching of patients with severe carotid stenosis to those with mild or no stenosis.

Main Results:

  • No primary endpoints (cerebrovascular events or syncope) occurred in any patient.
  • Only three secondary endpoints occurred in two patients within the mild or no carotid stenosis group.
  • No significant difference in exaggerated hemodynamic responses to stress between groups (e.g., systolic BP drop > 20 mmHg).
  • Propensity-matched analysis included 62 patients with severe stenosis and 170 controls.

Conclusions:

  • Stress testing in patients with significant carotid stenosis did not demonstrate an increased risk of adverse events in this study.
  • No difference in exaggerated hemodynamic responses was observed between patients with and without carotid stenosis.
  • While results are reassuring, continued caution is advised due to the study's small sample size and limitations.
Abstract

Related Concept Videos

Exercise Stress Test01:26

Exercise Stress Test

Introduction
Exercise stress testing, commonly known as a treadmill test, is a noninvasive procedure used to evaluate cardiovascular function and diagnose heart conditions.
Definition
An exercise stress test measures the heart's response to exertion using a treadmill or stationary bicycle. Chest electrodes record the heart's electrical activity through an ECG, and blood pressure is monitored regularly.
Purposes
439
Imaging Studies for Cardiovascular System V: CT01:28

Imaging Studies for Cardiovascular System V: CT

Cardiac computed tomography (CT) scanning is an advanced cardiac imaging technique that utilizes CT technology, with or without intravenous (IV) contrast, to produce accurate cross-sectional virtual slices of specific areas of the heart, coronary circulation, and major blood vessels such as the aorta, pulmonary veins, and arteries. The computer processes these slices to generate three-dimensional images. Multidetector CT (MDCT) is a rapid form of CT scanning that captures multiple slices...
62
Antihypertensive Drugs: Vasodilators01:23

Antihypertensive Drugs: Vasodilators

Vasodilators, primarily affecting the smooth muscles within arterial and venous walls, are commonly used for hypertension treatment. Medications such as minoxidil and hydralazine primarily target arteries and arterioles, while sodium nitroprusside acts on arterioles and venules. Minoxidil, functioning as a prodrug, is metabolized by hepatic sulfotransferase into its active form, minoxidil sulfate, after oral administration. This metabolite binds to the sulfonylurea receptor (SUR) component of...
621
Heart Failure Drugs: β-Blockers01:22

Heart Failure Drugs: β-Blockers

β-adrenergic antagonists, commonly known as β-blockers, block the effects of sympathetic neurotransmitters such as noradrenaline (NA) and adrenaline (ADR). They have several beneficial effects in heart failure treatment. They reduce heart rate, the force of contraction, and cardiac muscle relaxation. They also slow the atrial-ventricular conduction rate and raise the threshold for arrhythmias. The concentration of β-blockers determines their effects on bronchodilation,...
418
Antianginal Drugs: Calcium Channel Blockers and Ranolazine01:25

Antianginal Drugs: Calcium Channel Blockers and Ranolazine

Angina pectoris, a primary symptom of ischemic heart disease, requires careful pharmacological interventions. In this context, calcium channel blockers (CCBs) and ranolazine have emerged as crucial pharmacotherapeutic agents, providing deep insights into the complexities of angina management.
CCBs, a diverse class that includes dihydropyridines (nifedipine) and diphenylalkylamines (verapamil and diltiazem), exert their effect by blocking calcium channels in cardiac and smooth muscle cells. This...
632
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
23